Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



BROSHY ERAN Create: Alert

All | News | Filings
Date FiledTypeDescription
08/23/2023 4 BROSHY ERAN (Director) has filed a Form 4 on Certara, Inc.
Txns: Bought 193 shares @ $16.1, valued at $3.1k
Bought 4,807 shares @ $15.8, valued at $76k
05/25/2023 4 BROSHY ERAN (Director) has filed a Form 4 on Certara, Inc.
Txns: Exercised 9,360 restricted stock units @ $0
Granted 8,663 restricted stock units @ $0
05/04/2023 4 BROSHY ERAN (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 9,132 shares @ $0
Granted 22,044 options to buy @ $10.95, valued at $241.4k
07/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
04/28/2022 4 BROSHY ERAN (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 9,852 shares @ $0
Granted 28,000 options to buy @ $10.15, valued at $284.2k
04/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/30/2020 4 BROSHY ERAN (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 6,635 shares @ $0
Granted 6,000 options to buy @ $30.14, valued at $180.8k
05/02/2019 4 BROSHY ERAN (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 8,385 shares @ $0
Granted 6,000 options to buy @ $23.85, valued at $143.1k
05/25/2018 4 BROSHY ERAN (Director) has filed a Form 4 on MAGELLAN HEALTH INC
Txns: Granted 1,685 shares @ $0
05/03/2018 4 BROSHY ERAN (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 8,186 shares @ $0
Granted 6,000 options to buy @ $24.43, valued at $146.6k
05/26/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/18/2017 4 BROSHY ERAN (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 6,000 shares @ $0
02/27/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/12/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
05/20/2016 4 BROSHY ERAN (Director) has filed a Form 4 on MAGELLAN HEALTH INC
Txns: Granted 2,295 shares @ $0
05/05/2016 4 BROSHY ERAN (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 6,000 shares @ $0
05/22/2015 4 BROSHY ERAN (Director) has filed a Form 4 on MAGELLAN HEALTH INC
Txns: Granted 2,235 shares @ $0
04/24/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
06/05/2014 4 BROSHY ERAN (Director) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 12,000 options to buy @ $23.51, valued at $282.1k
05/23/2014 4 BROSHY ERAN (Director) has filed a Form 4 on MAGELLAN HEALTH SERVICES INC
Txns: Granted 2,104 shares @ $0
05/24/2013 4 BROSHY ERAN (Director) has filed a Form 4 on MAGELLAN HEALTH SERVICES INC
Txns: Granted 2,367 shares @ $0
12/17/2012 5 Form 5 - Annual statement of changes in beneficial ownership of securities
05/17/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
05/20/2011 4 BROSHY ERAN (Director) has filed a Form 4 on MAGELLAN HEALTH SERVICES INC
Txns: Granted 2,414 shares @ $0
08/04/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
07/29/2010 4 BROSHY ERAN (Director) has filed a Form 4 on INVENTIV HEALTH INC
Txns: Gifted 13,355 shares @ $0
06/17/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
05/24/2010 4 BROSHY ERAN (Director) has filed a Form 4 on MAGELLAN HEALTH SERVICES INC
Txns: Granted 3,187 shares @ $0
12/17/2009 4 BROSHY ERAN (Director) has filed a Form 4 on NEUROGEN CORP
Txns: Granted 2,500 options to buy @ $0.1728, valued at $432
09/16/2009 4 BROSHY ERAN (Director) has filed a Form 4 on NEUROGEN CORP
06/16/2009 4 BROSHY ERAN (Director) has filed a Form 4 on NEUROGEN CORP
05/21/2009 4 BROSHY ERAN (Director) has filed a Form 4 on MAGELLAN HEALTH SERVICES INC
03/17/2009 4 BROSHY ERAN (Director) has filed a Form 4 on NEUROGEN CORP
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy